TEVA Earnings Teva Pharmaceutical Industries Ltd
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–43 of 43
| Q2 2026 | 2026-06-30 | -0.18 | 2026-07-29 | 10-Q |
| Q1 2026 | 2026-03-31 | 0.31 | 2026-04-29 | 10-Q |
| FY 2025 | 2025-12-31 | 1.21 | 2026-02-03 | 10-K |
| Q3 2025 | 2025-09-30 | 0.80 | 2025-11-05 | 10-Q |
| Q2 2026 | 2025-06-30 | 0.43 | 2026-07-29 | 10-Q |
| Q1 2026 | 2025-03-31 | 0.18 | 2026-04-29 | 10-Q |
| FY 2025 | 2024-12-31 | -1.45 | 2026-02-03 | 10-K |
| Q3 2025 | 2024-09-30 | -1.26 | 2025-11-05 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.87 | 2025-07-30 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.12 | 2025-05-07 | 10-Q |
| FY 2025 | 2023-12-31 | -0.50 | 2026-02-03 | 10-K |
| Q3 2024 | 2023-09-30 | -0.91 | 2024-11-06 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.98 | 2024-07-31 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.20 | 2024-05-08 | 10-Q |
| FY 2024 | 2022-12-31 | -2.20 | 2025-02-05 | 10-K |
| FY 2023 | 2022-09-30 | 0.05 | 2024-02-12 | 10-K |
| FY 2023 | 2022-06-30 | -0.23 | 2024-02-12 | 10-K |
| Q1 2023 | 2022-03-31 | -0.86 | 2023-05-10 | 10-Q |
| FY 2023 | 2021-12-31 | 0.38 | 2024-02-12 | 10-K |
| Q3 2022 | 2021-09-30 | 0.52 | 2022-11-03 | 10-Q |
| Q2 2022 | 2021-06-30 | 0.26 | 2022-07-27 | 10-Q |
| Q1 2022 | 2021-03-31 | 0.07 | 2022-05-03 | 10-Q |
| FY 2022 | 2020-12-31 | -3.64 | 2023-02-10 | 10-K |
| Q3 2021 | 2020-09-30 | -3.78 | 2021-10-27 | 10-Q |
| Q2 2021 | 2020-06-30 | 0.19 | 2021-07-28 | 10-Q |
| Q1 2021 | 2020-03-31 | 0.06 | 2021-04-28 | 10-Q |
| FY 2021 | 2019-12-31 | -0.91 | 2022-02-09 | 10-K |
| FY 2020 | 2019-09-30 | -0.29 | 2021-02-10 | 10-K |
| FY 2020 | 2019-06-30 | -0.63 | 2021-02-10 | 10-K |
| FY 2020 | 2019-03-31 | -0.10 | 2021-02-10 | 10-K |
| FY 2020 | 2018-12-31 | -2.35 | 2021-02-10 | 10-K |
| FY 2019 | 2018-09-30 | -0.27 | 2020-02-21 | 10-K |
| FY 2019 | 2018-06-30 | -0.24 | 2020-02-21 | 10-K |
| FY 2019 | 2018-03-31 | 1.03 | 2020-02-21 | 10-K |
| FY 2019 | 2017-12-31 | -16.26 | 2020-02-21 | 10-K |
| FY 2018 | 2017-09-30 | 0.52 | 2019-02-19 | 10-K |
| FY 2018 | 2017-06-30 | -5.94 | 2019-02-19 | 10-K |
| FY 2018 | 2017-03-31 | 0.57 | 2019-02-19 | 10-K |
| FY 2018 | 2016-12-31 | 0.07 | 2019-02-19 | 10-K |
| Q4 2017 | 2016-09-30 | 0.35 | 2018-02-12 | 10-K |
| Q4 2017 | 2016-06-30 | 0.20 | 2018-02-12 | 10-K |
| Q4 2017 | 2016-03-31 | 0.62 | 2018-02-12 | 10-K |
| Q4 2017 | 2015-12-31 | 1.82 | 2018-02-12 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.